HEADER TRANSFERASE 15-AUG-14 4UX0 OBSLTE 18-MAR-15 4UX0 5AM7 TITLE FGFR1 MUTANT WITH AN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 458-765; COMPND 5 SYNONYM: FGFR-1, BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1, BFGFR, COMPND 6 BFGF-R-1, FMS-LIKE TYROSINE KINASE 2, FLT-2, N-SAM, PROTO-ONCOGENE COMPND 7 C-FGR, FIBROBLAST GROWTH FACTOR 1; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: C41 LAMBDA 37; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PJ821 KEYWDS TRANSFERASE, INHIBITOR, DRUG, CANCER, FGF, RECEPTORS, GROWTH KEYWDS 2 FACTORS, SIGNALLING, ENZYME EXPDTA X-RAY DIFFRACTION AUTHOR N.THIYAGARAJAN,T.BUNNEY,M.KATAN REVDAT 2 18-MAR-15 4UX0 1 OBSLTE REVDAT 1 25-FEB-15 4UX0 0 JRNL AUTH T.BUNNEY,S.WAN,N.THIYAGARAJAN,L.SUTTO,S.V.WILLIAMS, JRNL AUTH 2 P.ASHFORD,H.KOSS,M.A.KNOWLES,F.L.GERVASIO,P.V.COVENEY, JRNL AUTH 3 M.KATAN JRNL TITL THE EFFECT OF MUTATIONS ON DRUG SENSITIVITY AND KINASE JRNL TITL 2 ACTIVITY OF FIBROBLAST GROWTH FACTOR RECEPTORS: A COMBINED JRNL TITL 3 EXPERIMENTAL AND THEORETICAL STUDY JRNL REF EBIOMEDICINE 2015 JRNL REFN ESSN 2352-3964 JRNL DOI 10.1016/J.EBIOM.2015.02.009 REMARK 2 REMARK 2 RESOLUTION. 1.96 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.957 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.917 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.33 REMARK 3 COMPLETENESS FOR RANGE (%) : 82.71 REMARK 3 NUMBER OF REFLECTIONS : 44767 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.2017 REMARK 3 R VALUE (WORKING SET) : 0.1989 REMARK 3 FREE R VALUE : 0.2550 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 2256 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.9206 - 4.9236 0.99 3320 155 0.1612 0.2190 REMARK 3 2 4.9236 - 3.9111 0.99 3201 178 0.1452 0.1996 REMARK 3 3 3.9111 - 3.4176 0.97 3115 181 0.1747 0.2207 REMARK 3 4 3.4176 - 3.1055 0.99 3189 184 0.2019 0.2441 REMARK 3 5 3.1055 - 2.8831 1.00 3227 150 0.2235 0.2902 REMARK 3 6 2.8831 - 2.7133 1.00 3208 161 0.2273 0.2733 REMARK 3 7 2.7133 - 2.5775 1.00 3210 175 0.2253 0.2827 REMARK 3 8 2.5775 - 2.4654 1.00 3187 181 0.2326 0.2975 REMARK 3 9 2.4654 - 2.3705 1.00 3170 180 0.2259 0.2639 REMARK 3 10 2.3705 - 2.2887 0.95 3090 126 0.2336 0.2978 REMARK 3 11 2.2887 - 2.2172 0.74 2337 127 0.4217 0.5889 REMARK 3 12 2.2172 - 2.1538 0.74 2325 164 0.2563 0.3239 REMARK 3 13 2.1538 - 2.0971 0.62 2011 102 0.2436 0.2892 REMARK 3 14 2.0971 - 2.0460 0.52 1639 76 0.2758 0.3191 REMARK 3 15 2.0460 - 1.9995 0.43 1358 78 0.2808 0.3146 REMARK 3 16 1.9995 - 1.9570 0.29 924 38 0.2943 0.3999 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.25 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.93 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 4795 REMARK 3 ANGLE : 1.372 6482 REMARK 3 CHIRALITY : 0.062 727 REMARK 3 PLANARITY : 0.007 816 REMARK 3 DIHEDRAL : 14.810 1880 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 226.9054 -11.1761 28.6900 REMARK 3 T TENSOR REMARK 3 T11: 0.1847 T22: 0.2601 REMARK 3 T33: 0.2556 T12: -0.0052 REMARK 3 T13: 0.0113 T23: -0.0360 REMARK 3 L TENSOR REMARK 3 L11: 0.0762 L22: 0.4187 REMARK 3 L33: 0.9141 L12: 0.0411 REMARK 3 L13: 0.1213 L23: -0.3639 REMARK 3 S TENSOR REMARK 3 S11: 0.0142 S12: 0.0157 S13: -0.0417 REMARK 3 S21: 0.0581 S22: -0.0342 S23: -0.0250 REMARK 3 S31: -0.0314 S32: 0.0447 S33: 0.0272 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4UX0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-SEP-14. REMARK 100 THE PDBE ID CODE IS EBI-61545. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JUL-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9686 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL (PILATUS 6M) REMARK 200 DETECTOR MANUFACTURER : DECTRIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45034 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.96 REMARK 200 RESOLUTION RANGE LOW (A) : 28.92 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.2 REMARK 200 DATA REDUNDANCY : 3.8 REMARK 200 R MERGE (I) : 0.05 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.00 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 29.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.0 REMARK 200 R MERGE FOR SHELL (I) : 0.32 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.90 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.6 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 % PEG 5K MME, 0.1 M TRIS, PH 7.5, REMARK 280 0.2 M (NH4)2SO4 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 104.30300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.91750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 104.30300 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.91750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 456 REMARK 465 VAL A 457 REMARK 465 GLY A 487 REMARK 465 ALA A 488 REMARK 465 PHE A 489 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 SER A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 GLU A 765 REMARK 465 MET B 456 REMARK 465 VAL B 457 REMARK 465 GLY B 487 REMARK 465 ALA B 488 REMARK 465 PHE B 489 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 465 HIS B 650 REMARK 465 ILE B 651 REMARK 465 ASP B 652 REMARK 465 ASN B 763 REMARK 465 GLN B 764 REMARK 465 GLU B 765 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 646 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N GLY A 490 CD LYS A 517 1.79 REMARK 500 N GLY A 490 CE LYS A 517 1.93 REMARK 500 O SER A 518 O HOH A 2018 2.03 REMARK 500 OD1 ASN B 659 O HOH B 2038 2.16 REMARK 500 O HOH A 2094 O HOH A 2099 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 519 CB - CG - OD1 ANGL. DEV. = 6.2 DEGREES REMARK 500 PRO B 579 C - N - CD ANGL. DEV. = -13.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 502 28.56 -79.70 REMARK 500 GLU A 592 -142.76 -125.76 REMARK 500 ARG A 622 -13.67 82.16 REMARK 500 ASP A 623 42.44 -141.70 REMARK 500 CYS A 725 129.07 -178.92 REMARK 500 LYS B 502 32.82 -80.82 REMARK 500 PRO B 578 -164.14 -73.95 REMARK 500 GLU B 593 80.21 74.78 REMARK 500 ARG B 622 -12.88 79.74 REMARK 500 ASP B 623 40.77 -141.85 REMARK 500 ASN B 659 -79.41 -153.14 REMARK 500 CYS B 725 130.19 -176.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 THR B 658 ASN B 659 -130.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2073 DISTANCE = 5.38 ANGSTROMS REMARK 525 HOH B2065 DISTANCE = 5.34 ANGSTROMS REMARK 525 HOH B2085 DISTANCE = 7.74 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1767 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1765 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B1763 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DOV A1766 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DOV B1764 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UWY RELATED DB: PDB REMARK 900 FGFR1 APO STRUCTURE REMARK 900 RELATED ID: 4UWZ RELATED DB: PDB REMARK 900 NATIVE FGFR1 WITH AN INHIBITOR DBREF 4UX0 A 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 4UX0 B 458 765 UNP P11362 FGFR1_HUMAN 458 765 SEQADV 4UX0 MET A 456 UNP P11362 EXPRESSION TAG SEQADV 4UX0 VAL A 457 UNP P11362 EXPRESSION TAG SEQADV 4UX0 ALA A 488 UNP P11362 CYS 488 CONFLICT SEQADV 4UX0 MET A 561 UNP P11362 VAL 561 ENGINEERED MUTATION SEQADV 4UX0 SER A 584 UNP P11362 CYS 584 CONFLICT SEQADV 4UX0 MET B 456 UNP P11362 EXPRESSION TAG SEQADV 4UX0 VAL B 457 UNP P11362 EXPRESSION TAG SEQADV 4UX0 ALA B 488 UNP P11362 CYS 488 CONFLICT SEQADV 4UX0 MET B 561 UNP P11362 VAL 561 ENGINEERED MUTATION SEQADV 4UX0 SER B 584 UNP P11362 CYS 584 CONFLICT SEQRES 1 A 310 MET VAL ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP SEQRES 2 A 310 PRO ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY SEQRES 3 A 310 LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU SEQRES 4 A 310 ALA GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG SEQRES 5 A 310 VAL THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA SEQRES 6 A 310 THR GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU SEQRES 7 A 310 MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN SEQRES 8 A 310 LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL SEQRES 9 A 310 ILE MET GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR SEQRES 10 A 310 LEU GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR SEQRES 11 A 310 ASN PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS SEQRES 12 A 310 ASP LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 13 A 310 GLU TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU SEQRES 14 A 310 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 15 A 310 LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS SEQRES 16 A 310 ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO SEQRES 17 A 310 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE SEQRES 18 A 310 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU SEQRES 19 A 310 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 20 A 310 GLY VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU SEQRES 21 A 310 GLY HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU SEQRES 22 A 310 LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SEQRES 23 A 310 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU SEQRES 24 A 310 ASP ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 310 MET VAL ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP SEQRES 2 B 310 PRO ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY SEQRES 3 B 310 LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU SEQRES 4 B 310 ALA GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG SEQRES 5 B 310 VAL THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA SEQRES 6 B 310 THR GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU SEQRES 7 B 310 MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN SEQRES 8 B 310 LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL SEQRES 9 B 310 ILE MET GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR SEQRES 10 B 310 LEU GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR SEQRES 11 B 310 ASN PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS SEQRES 12 B 310 ASP LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 13 B 310 GLU TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU SEQRES 14 B 310 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 15 B 310 LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS SEQRES 16 B 310 ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO SEQRES 17 B 310 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE SEQRES 18 B 310 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU SEQRES 19 B 310 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 20 B 310 GLY VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU SEQRES 21 B 310 GLY HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU SEQRES 22 B 310 LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SEQRES 23 B 310 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU SEQRES 24 B 310 ASP ARG ILE VAL ALA LEU THR SER ASN GLN GLU HET CL A1767 1 HET CL A1765 1 HET CL B1763 1 HET DOV A1766 29 HET DOV B1764 29 HETNAM CL CHLORIDE ION HETNAM DOV 1-AMINO-5-FLUORO-3-(6-(4-METHYLPIPERAZIN-1- HETNAM 2 DOV YL)-1H-BENZO[D]IMIDAZOL-2-YL)QUINOLIN-2(1H)- HETNAM 3 DOV ONE FORMUL 3 CL 3(CL 1-) FORMUL 4 DOV 2(C21 H37 F N6 O) FORMUL 5 HOH *216(H2 O) HELIX 1 1 PRO A 474 ASP A 476 5 3 HELIX 2 2 THR A 521 GLY A 539 1 19 HELIX 3 3 ASN A 568 ALA A 575 1 8 HELIX 4 4 SER A 596 LYS A 617 1 22 HELIX 5 5 ALA A 625 ARG A 627 5 3 HELIX 6 6 ASP A 647 ILE A 651 5 5 HELIX 7 7 LEU A 662 MET A 667 5 6 HELIX 8 8 ALA A 668 ARG A 675 1 8 HELIX 9 9 THR A 678 THR A 695 1 18 HELIX 10 10 PRO A 705 GLU A 715 1 11 HELIX 11 11 THR A 726 TRP A 737 1 12 HELIX 12 12 VAL A 740 ARG A 744 5 5 HELIX 13 13 THR A 746 THR A 761 1 16 HELIX 14 14 PRO B 474 ASP B 476 5 3 HELIX 15 15 THR B 521 GLY B 539 1 19 HELIX 16 16 ASN B 568 ALA B 575 1 8 HELIX 17 17 SER B 596 LYS B 617 1 22 HELIX 18 18 ALA B 625 ARG B 627 5 3 HELIX 19 19 LEU B 662 MET B 667 5 6 HELIX 20 20 ALA B 668 ARG B 675 1 8 HELIX 21 21 THR B 678 THR B 695 1 18 HELIX 22 22 PRO B 705 GLU B 715 1 11 HELIX 23 23 THR B 726 TRP B 737 1 12 HELIX 24 24 VAL B 740 ARG B 744 5 5 HELIX 25 25 THR B 746 LEU B 760 1 15 SHEET 1 AA 5 LEU A 478 GLY A 485 0 SHEET 2 AA 5 GLN A 491 ILE A 498 -1 O VAL A 492 N LEU A 484 SHEET 3 AA 5 VAL A 508 MET A 515 -1 O THR A 509 N ALA A 497 SHEET 4 AA 5 TYR A 558 GLU A 562 -1 O VAL A 559 N LYS A 514 SHEET 5 AA 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 AB 2 VAL A 629 VAL A 631 0 SHEET 2 AB 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 BA 5 LEU B 478 GLY B 485 0 SHEET 2 BA 5 GLN B 491 ILE B 498 -1 O VAL B 492 N LEU B 484 SHEET 3 BA 5 VAL B 508 MET B 515 -1 O THR B 509 N ALA B 497 SHEET 4 BA 5 TYR B 558 GLU B 562 -1 O VAL B 559 N LYS B 514 SHEET 5 BA 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 BB 2 VAL B 629 VAL B 631 0 SHEET 2 BB 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 CISPEP 1 VAL A 460 SER A 461 0 16.43 CISPEP 2 ASN B 659 GLY B 660 0 -13.05 SITE 1 AC1 1 LYS A 618 SITE 1 AC2 4 ARG A 570 ARG A 627 ARG A 661 HOH A2069 SITE 1 AC3 3 ARG B 570 ARG B 627 ARG B 661 SITE 1 AC4 10 VAL A 492 ALA A 512 ILE A 545 MET A 561 SITE 2 AC4 10 GLU A 562 TYR A 563 ALA A 564 SER A 565 SITE 3 AC4 10 GLY A 567 LEU A 630 SITE 1 AC5 11 LEU B 484 ALA B 512 ILE B 545 MET B 561 SITE 2 AC5 11 GLU B 562 TYR B 563 ALA B 564 SER B 565 SITE 3 AC5 11 LYS B 566 GLY B 567 LEU B 630 CRYST1 208.606 57.835 65.622 90.00 107.40 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004794 0.000000 0.001502 0.00000 SCALE2 0.000000 0.017291 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015970 0.00000